EVALUATION OF THE EFFICACY OF NANOPARTICLES CONTAINING 1 PENTAMIDINE FOR THE TREATMENT OF LEISHMANIOSE TEGUMENTAR 2 3
暂无分享,去创建一个
C. Corrêa | E. D. P. Almeida | A. M. Lira | R. Nunes | R. Scher | F. B. Felix | Gitika De | Audrey Silva | M. Santos | Araújo
[1] Mohamed A Al-Kamel. Leishmaniasis and Malignancy: A Review and Perspective , 2017 .
[2] M. Moazeni,et al. Improved yeast delivery of fluconazole with a nanostructured lipid carrier system. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[3] S. Bahrami,et al. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum , 2017, Pathogens and global health.
[4] José Alexsandro da Silva,et al. Evaluation of Microemulsion and Lamellar Liquid Crystalline Systems for Transdermal Zidovudine Delivery. , 2016, Journal of pharmaceutical sciences.
[5] Chetna K. Desai. Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions , 2016, Indian Journal of Pharmacology.
[6] D. Gaspar,et al. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. , 2016, International journal of pharmaceutics.
[7] S. Guterres,et al. Co-encapsulation of imiquimod and copaiba oil in novel nanostructured systems: promising formulations against skin carcinoma. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] G. Zhai,et al. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation. , 2014, International journal of pharmaceutics.
[9] A. Silva,et al. Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - a systematic review of in vitro data. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] S. Sundar,et al. Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani , 2013, Parasitology Research.
[11] R. Tan,et al. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[12] H. Goto,et al. Cutaneous and mucocutaneous leishmaniasis. , 2012, Infectious disease clinics of North America.
[13] R. Suryanarayanan,et al. Physical characterization of pentamidine isethionate during freeze-drying-relevance to development of stable lyophilized product. , 2012, Journal of pharmaceutical sciences.
[14] I. Sramala,et al. Production of nisin-loaded solid lipid nanoparticles for sustained antimicrobial activity , 2012 .
[15] F. Atyabi,et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method , 2012, International journal of nanomedicine.
[16] Sanjay Singh,et al. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. , 2011, Colloids and surfaces. B, Biointerfaces.
[17] P. Shelat,et al. Nanoemulsion: A pharmaceutical review , 2010 .
[18] Hong Yuan,et al. Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. , 2008, International journal of pharmaceutics.
[19] M. Kalis,et al. Characterization of pentamidine excretion in the isolated perfused rat kidney. , 2003, The Journal of antimicrobial chemotherapy.
[20] Challa S. S. R. Kumar,et al. Nanotechnology tools in pharmaceutical R&D , 2010 .